The Dean of Mumbai's JJ Hospital where Indrani Mukerjea was admitted said that a medical test confirmed that she overdosed on an antidepressant.
Indrani was admitted to JJ hospital in Mumbai late on Friday night after complaining of uneasiness and difficulty in breathing.
"Overdose of benzodiazepine was suspected and that is what has come out positive in the test," JJ Hospital Dean SD Nanandkar told ANI on Monday.
On April 7, Nanandkarp said the preliminary test of Indrani indicates a case of poisoning or drug overdose adding that the hospital authority is waiting for the final reports.
Indrani is currently serving jail term in Byculla women's jail in connection with the murder of her daughter Sheena Bora.
Earlier today, Additional Director General, Prisons, Bhushan Upadhyay said that Rajvardhan, Inspector General (IG), Prisons, is directed to conduct a detailed inquiry in the incident.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
